March 7 (Reuters) - Spectral Medical Inc EDT.TO
* U.S. FDA approves Spectral's third PMA module for its toraymyxin treatment of endotoxemic septic shock
* Spectral Medical Inc - "plan to file our fourth and final module containing clinical data early in Q2 of this year" Source text for Eikon: Further company coverage: EDT.TO